Table of Contents

company-logo

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Arecor Therapeutics Dividend Announcement

• Arecor Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Arecor Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Arecor Therapeutics Dividend History

Arecor Therapeutics Dividend Yield

Arecor Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Arecor Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Arecor Therapeutics Financial Ratios

P/E ratio-2.65
PEG ratio16.41
P/B ratio4.52
ROE-118.67%
Payout ratio0.00%
Current ratio1.37
Quick ratio1.27
Cash Ratio0.54

Arecor Therapeutics Dividend FAQ

Does Arecor Therapeutics stock pay dividends?
Arecor Therapeutics does not currently pay dividends to its shareholders.
Has Arecor Therapeutics ever paid a dividend?
No, Arecor Therapeutics has no a history of paying dividends to its shareholders. Arecor Therapeutics is not known for its dividend payments.
Why doesn't Arecor Therapeutics pay dividends?
There are several potential reasons why Arecor Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Arecor Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Arecor Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Arecor Therapeutics a dividend aristocrat?
Arecor Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Arecor Therapeutics a dividend king?
Arecor Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Arecor Therapeutics a dividend stock?
No, Arecor Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Arecor Therapeutics stocks?
To buy Arecor Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Arecor Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.